NASDAQ
APEN

Apollo Endosurgery Inc

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
LIFE SCIENCES

Prices are adjusted according to historical splits.

Apollo Endosurgery Inc Stock Price

Vitals

Today's Low:
$6.4010
Today's High:
$7.2700
Open Price:
$7.2700
52W Low:
$3.49
52W High:
$10.39
Prev. Close:
$6.6100
Volume:
555601

Company Statistics

Market Cap.:
$0.273 billion
Book Value:
1.189
Revenue TTM:
$0.068 billion
Operating Margin TTM:
-35.1%
Gross Profit TTM:
$0.035 billion
Gross Profit TTM:
$0.035 billion
Profit Margin:
-52.4%
Return on Assets TTM:
-15.4%
Return on Equity TTM:
-141.1%

Company Profile

Apollo Endosurgery Inc had its IPO on 2005-12-09 under the ticker symbol APEN.

The company operates in the LIFE SCIENCES sector and SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry. Apollo Endosurgery Inc has a staff strength of 0 employees.

Stock update

Shares of Apollo Endosurgery Inc opened at $7.27 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $6.4 - $7.27, and closed at $6.66.

This is a +0.76% increase from the previous day's closing price.

A total volume of 555,601 shares were traded at the close of the day’s session.

In the last one week, shares of Apollo Endosurgery Inc have increased by +11%.

Apollo Endosurgery Inc's Key Ratios

Apollo Endosurgery Inc has a market cap of $0.273 billion, indicating a price to book ratio of 5.3 and a price to sales ratio of 3.992.

In the last 12-months Apollo Endosurgery Inc’s revenue was $0.068 billion with a gross profit of $0.035 billion and an EBITDA of $-0.021 billion. The EBITDA ratio measures Apollo Endosurgery Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Apollo Endosurgery Inc’s operating margin was -35.1% while its return on assets stood at -15.4% with a return of equity of -141.1%.

In Q3, Apollo Endosurgery Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 16.2%.

Apollo Endosurgery Inc’s PE and PEG Ratio

Forward PE
-
Trailing PE
-
PEG
0

Its diluted EPS in the last 12-months stands at $-0.849 per share while it has a forward price to earnings multiple of - and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Apollo Endosurgery Inc’s profitability.

Apollo Endosurgery Inc stock is trading at a EV to sales ratio of 3.419 and a EV to EBITDA ratio of -9.52. Its price to sales ratio in the trailing 12-months stood at 3.992.

Apollo Endosurgery Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0.000 billion
Total Liabilities
$0.000 billion
Operating Cash Flow
$0.000 billion
Capital Expenditure
$0.000 billion
Dividend Payout Ratio
0%

Apollo Endosurgery Inc ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Apollo Endosurgery Inc ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Apollo Endosurgery Inc’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Apollo Endosurgery Inc's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Apollo Endosurgery Inc paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price
$6.66
52-Week High
$10.39
52-Week Low
$3.49
Analyst Target Price
$12.6

Apollo Endosurgery Inc stock is currently trading at $6.66 per share. It touched a 52-week high of $10.39 and a 52-week low of $10.39. Analysts tracking the stock have a 12-month average target price of $12.6.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Apollo Endosurgery Inc

The stock symbol (also called stock or share ticker) of Apollo Endosurgery Inc is APEN

The IPO of Apollo Endosurgery Inc took place on 2005-12-09

Similar Industry Stocks (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS)

Last Price
Chg
Chg%
Tela Bio Inc (TELA)
$8.48
-0.23
-2.64%
$2.6
0
0%
$22.69
-0.77
-3.28%
$211.97
-8.12
-3.69%
$6.83
-0.18
-2.57%

Most Active

Last Price
Chg
Chg%
$58.63
-1.03
-1.73%
$92.12
-4.67
-4.82%
$5.12
-0.61
-10.65%
Apple Inc (AAPL)
$145.03
-5.62
-3.73%
$0.06
0.01
+12.74%

Top Gainers

Last Price
Chg
Chg%
$73
42.7
+140.92%
Oi S.A (OIBR-C)
$0
0
+100%
$0.02
0.01
+100%
$0.25
0.1
+66.44%
$2.85
1.01
+54.86%

Top Losers

Last Price
Chg
Chg%
$5.36
-22.58
-80.82%
$0.02
-0.06
-78.67%
Air T, Inc (AIRTW)
$0.01
-0.03
-75%
$4.51
-5.17
-53.41%
$11.5
-12.2
-51.48%

About

Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development and marketing of medical devices. The company is headquartered in Austin, Texas.

Address

1120 SOUTH CAPITAL OF TX HWY, BUILDING 1 SUITE 300, AUSTIN, TX, US